Showing results (241-250 of 251) with videos related to
Sort By:
Pageof 26
The British Journal of Dermatology|December 11, 2007
Inpatient management of psoriasis: a multicentre service review to establish national admission standardsA L Woods, K J Rutter, L S Gardner, et al.The British Journal of Dermatology|September 21, 2011
Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and IrelandP M Laws, A M Downs, R Parslew, et al.The British Journal of Dermatology|June 21, 2020
Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysisS K Mahil, M C Ezejimofor, L S Exton, et al.Oncogene|May 10, 2011
Shared acquired genomic changes in zebrafish and human T-ALLL A Rudner, K H Brown, K P Dobrinski, et al.The Journal of Clinical Investigation|April 15, 2011
Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in miceAubrey C Chan, Stavros G Drakos, Oscar E Ruiz, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 12, 2016
UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016D Creamer, S A Walsh, P Dziewulski, et al.The British Journal of Dermatology|January 15, 2013
Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)L C Coates, T Aslam, F Al Balushi, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 24, 2022
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)J Zitouni, A-C Bursztejn, A Belloni Fortina, et al.The British Journal of Dermatology|August 19, 2021
Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)S Cro, V R Cornelius, A E Pink, et al.The British Journal of Dermatology|December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient surveyS K Mahil, M Yates, S M Langan, et al.Pageof 26